2014 ACR/ARHP Annual Meeting: Patient-Centered Outcomes Research Gaining Support

As an example, Dr. Curtis described his involvement in a large pragmatic trial about the live herpes zoster vaccine in RA patients using TNF therapy. The researchers used data from Medicare combined with data from the Consortium of Rheumatology Researchers of North America (CORRONA) disease registry to determine whether it was feasible to recruit 4,000 patients and to help select sites for the research. As a result, more than 12,000 potentially eligible patients were identified from the 50 largest rheumatology practices.¹

A registry, such as CORRONA, “already has the data to answer a research question,” he said.

Kathy L. Holliman, MEd, is a medical writer based in Beverly, Mass.

References

1. Curtis JR, Wright NC, Xie F, et al. Use of health plan combined with registry data to predict clinical trial recruitment. Clin Trials. 2014;11(1):96–101.